Study Evaluating the Safety of Rovalpituzumab Tesirine for Third-Line and Later Treatment of Subjects With Relapsed or Refractory Small Cell Lung Cancer
Public ClinicalTrials.gov record NCT03334487. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Open-Label, Single Arm, Phase 3b Study Evaluating the Safety of Rovalpituzumab Tesirine for Third-Line and Later Treatment of Subjects With Relapsed or Refractory DLL3 Expressing Small Cell Lung Cancer
Study identification
- NCT ID
- NCT03334487
- Recruitment status
- Withdrawn
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- AbbVie
- Industry
- Enrollment
- Not listed
Conditions and interventions
Conditions
Interventions
- Dexamethasone Drug
- Rovalpituzumab tesirine Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 14, 2018
- Primary completion
- Dec 19, 2018
- Completion
- Dec 19, 2018
- Last update posted
- Dec 25, 2018
2018
United States locations
- U.S. sites
- 27
- U.S. states
- 16
- U.S. cities
- 26
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Ironwood Cancer & Res Ctr /ID# 171335 | Chandler | Arizona | 85224-5665 | — |
| Mayo Clinic - Scottsdale /ID# 171359 | Scottsdale | Arizona | 85259 | — |
| VA Central California Health C /ID# 170951 | Fresno | California | 93703 | — |
| Loma Linda University Medical /ID# 171377 | Loma Linda | California | 92354 | — |
| UC Irvine Health /ID# 171343 | Orange | California | 92868-3201 | — |
| Kaiser Permanente - Roseville /ID# 200779 | Roseville | California | 95661-3027 | — |
| Kaiser Permanente-Santa Clara /ID# 203024 | Santa Clara | California | 95051-5173 | — |
| Kaiser Permanente Medical Ctr-Vallejo /ID# 169758 | Vallejo | California | 94589-2441 | — |
| Kaiser Permanente- Walnut Creek /ID# 201305 | Walnut Creek | California | 94596 | — |
| Univ of Colorado Cancer Center /ID# 200810 | Aurora | Colorado | 80045 | — |
| Boca Raton Regional Hospital /ID# 200168 | Boca Raton | Florida | 33486 | — |
| UMHC/Sylvester Comprehensive /ID# 171462 | Deerfield Beach | Florida | 33442 | — |
| Mount Sinai Comp Cancer Ctr /ID# 169759 | Miami | Florida | 33140 | — |
| Illinois Cancer Care, PC /ID# 171310 | Peoria | Illinois | 61615 | — |
| Baptist Health /ID# 171379 | Lexington | Kentucky | 40503-1463 | — |
| Norton Cancer Institute /ID# 200827 | Louisville | Kentucky | 40202-3700 | — |
| Tulane Cancer Center Clinic /ID# 171376 | New Orleans | Louisiana | 70112 | — |
| Sandra Malcolm Berman Cncr Ins /ID# 171346 | Baltimore | Maryland | 21204 | — |
| St. Luke's University Hospital /ID# 171374 | Duluth | Minnesota | 55802 | — |
| Valley Hospital - Westwood, NJ /ID# 171357 | Westwood | New Jersey | 07675 | — |
| Wake Forest Baptist Medical Center /ID# 169799 | Winston-Salem | North Carolina | 27157-0001 | — |
| The Ohio State University Comp /ID# 171352 | Columbus | Ohio | 43210 | — |
| St. Luke's Hematology Oncology /ID# 171378 | Bethlehem | Pennsylvania | 18015 | — |
| Tennessee Oncology PLLC: Sarah /ID# 171380 | Nashville | Tennessee | 37203 | — |
| Vanderbilt Ingram Henry Cancer /ID# 171356 | Nashville | Tennessee | 37212 | — |
| VCS, Virginia Cancer Specialis /ID# 169760 | Arlington | Virginia | 22031 | — |
| Kadlec Clinic Hematology and O /ID# 169797 | Kennewick | Washington | 99336 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 33 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03334487, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 25, 2018 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03334487 live on ClinicalTrials.gov.